G(D2) OLIGOSACCHARIDE - TARGET FOR CYTOTOXIC T-LYMPHOCYTES

被引:46
|
作者
ZHAO, XJ [1 ]
CHEUNG, NKV [1 ]
机构
[1] MEM SLOAN KETTERING CANC CTR,DEPT PEDIAT,NEW YORK,NY 10021
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1995年 / 182卷 / 01期
关键词
D O I
10.1084/jem.182.1.67
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Carbohydrate antigens rarely provide target epitopes for cytotoxic T lymphocytes (CTL). Disialoganglioside G(D2) is a glycolipid expressed at high levels in human tumors and a small group of murine lymphomas (EL4, RBL5, RMA, RMA-S, A13, and BALBRVE). Immunization of C57Bl/6 mice with irradiated EL4 cells stimulated a specific CTL response and protected these animals from engraftment of EL4 lymphoma. The CTL activity resided in the CD4(-)CD8(+) population, was dependent on T cell receptor alpha/beta, and was not removed by anti-natural killer cell immunoabsorption, but was restricted to G(D2) and H-2(b) bearing targets. CTL activity could be completely inhibited by G(D2)-oligosaccharide-specific monoclonal antibodies and their F(ab')(2) fragments, but not by immunoglobulin G(3) myelomas or antibodies against G(D3) or G(M2). Soluble G(D2) did not inhibit specific tumor lysis. RMA-S lymphoma cells (G(D2)(+)H-2b(-)TAP(2) deficient) were resistant to G(D2)-specific CTL. Sialic acid-containing peptides eluted from EL4 lymphoma cells could (a) stabilize H-2 molecules on RMA-S cells and (b) sensitize them for G(D2)-specific CTL. Control peptides (derived from vesicular stomatitis virus nucleoprotein peptide and G(D2)-negative lymphomas) could also stabilize H-2 on RMA-S, but were resistant to G(D2)-specific CTL. These H-2-binding peptides could be purified by anti-G(D2) affinity chromatography. We postulate a new class of naturally occurring epitopes for T cells where branched-chain oligosaccharides are linked to peptides with anchoring motifs for the major histocompatibility complex class I pocket. While analogous to the haptens trinitrophenyl and O-beta-linked acetyl-glucosamine, the potential implications of natural carbohydrates as antigenic epitopes for CTL in biology are considerable.
引用
收藏
页码:67 / 74
页数:8
相关论文
共 50 条
  • [41] TUMOR-ERADICATION BY ADOPTIVE TRANSFER OF CYTOTOXIC T-LYMPHOCYTES
    MELIEF, CJM
    [J]. ADVANCES IN CANCER RESEARCH, 1992, 58 : 143 - 175
  • [42] INDUCTION OF HUMAN AUTOLOGOUS CYTOTOXIC T-LYMPHOCYTES WITH CYTOKINE COCKTAILS
    OHNO, T
    LIU, SQ
    SAIJO, K
    TODOROKI, T
    OKIGAKI, T
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1995, 6 : 96 - 96
  • [43] PRIMARY INVITRO SENSITIZATION OF VIRUS SPECIFIC CYTOTOXIC T-LYMPHOCYTES
    JUNG, H
    PFIZENMAIER, K
    STARZINSKIPOWITZ, A
    ROLLINGHOFF, M
    WAGNER, H
    [J]. IMMUNOLOGY, 1978, 34 (04) : 763 - 769
  • [44] FREQUENCY OF EFFECTOR CELLS IN POPULATIONS CONTAINING CYTOTOXIC T-LYMPHOCYTES
    BERKE, G
    GABISON, D
    FELDMAN, M
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1975, 5 (12) : 813 - 818
  • [45] THE ROLE OF ETHER-LINKED GLYCEROPHOSPHOLIPIDS IN CYTOTOXIC T-LYMPHOCYTES
    NISHIHIRA, J
    ISHIBASHI, T
    SAWAMURA, Y
    HOSOKAWA, M
    [J]. BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL, 1994, 33 (01): : 137 - 146
  • [46] OBSERVATIONS ON MECHANISM BY WHICH T-LYMPHOCYTES EXERT CYTOTOXIC EFFECTS
    FERLUGA, J
    ALLISON, AC
    [J]. NATURE, 1974, 250 (5468) : 673 - 675
  • [47] PNEUMONITIS SECONDARY TO EBV-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
    Nieweld, Carl
    Hilton, Robert
    Summer, Ross
    [J]. CHEST, 2018, 154 (04) : 423A - 423A
  • [48] CYTOTOXIC ACTIVITIES OF PERFORIN-DEFICIENT MUTANT T-LYMPHOCYTES
    KOJIMA, H
    SHINOHARA, N
    HANAOKA, S
    SHIROTASOMEYA, Y
    OHNO, H
    SAITO, T
    KAWASAKI, A
    YAGITA, H
    OKUMURA, K
    SHINKAI, Y
    ALT, FW
    TAKAYAMA, H
    [J]. FASEB JOURNAL, 1994, 8 (04): : A206 - A206
  • [49] CROSS-REACTIVITY PATTERNS OF MURINE CYTOTOXIC T-LYMPHOCYTES
    MULLBACHER, A
    BLANDEN, RV
    [J]. CELLULAR IMMUNOLOGY, 1979, 43 (01) : 70 - 81
  • [50] Leukemic stem cells are immunogenic targets for cytotoxic T-lymphocytes
    Schneider, V
    Zhang, L.
    Rojewski, M.
    Fekete, N.
    Erle, A.
    Bullinger, L.
    Hofmann, S.
    Goetz, M.
    Doehner, K.
    Ihme, S.
    Doehner, H.
    Buske, C.
    Greiner, J.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 240 - 240